Esperto Medical™, Inc. has been awarded a prestigious grant by the Midwest Pediatric Device Consortium (MPDC) to advance its pioneering noninvasive vital sign monitoring technology for pediatric use. This recognition marks a crucial step in addressing a significant gap in pediatric care—where children often lack access to advanced monitoring tools readily available to adults. Leveraging its proprietary Resonance Sonomanometry™ (RSM) technology, Esperto aims to create a continuous, calibration-free solution for monitoring vital signs in children, offering a safer and more adaptable alternative for critical care and remote settings.

The new device, powered by RSM, uses sound waves at varying frequencies to directly measure blood pressure inside arteries without the need for traditional cuffs or calibration procedures. This simplifies setup and increases accuracy while minimizing discomfort—an essential benefit for children in intensive care or long-term monitoring scenarios. Designed to accommodate the physiological diversity of pediatric patients, the technology offers a noninvasive, real-time view into a child's circulatory health, helping clinicians detect complications earlier and intervene faster. Such innovation could be transformative for clinicians working in fast-paced environments where continuous, reliable monitoring is critical.

Looking forward, the funding will support development, refinement, and clinical trials of the pediatric version of the device, bringing Esperto’s technology one step closer to real-world application. Backed by the FDA-supported Pediatric Device Consortium program, this initiative not only validates Esperto’s technical vision but also contributes to the broader mission of making state-of-the-art care accessible to even the youngest and most vulnerable patients. As Esperto Medical continues to expand its technology across diverse age groups and care environments, it is well-positioned to reshape the future of pediatric monitoring and drive innovation that ensures no patient is left behind.